Yancey Holmes, MD
Endocrinology, Diabetes & Metabolism · Covington, KYNPI 1932177235
Payments from drug & device makers
Across 513 payments — averaging $288.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$99K
- AstraZeneca$31K
- Abbott$7K
- Tandem Diabetes Care, Inc.$6K
- Dexcom, Inc.$799
- Medtronic$603
- plus $3K from 32 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 180 | $99,297 |
| AstraZeneca(2 entities) | 41 | $30,824 |
| Abbott | 19 | $7,042 |
| Tandem Diabetes Care, Inc. | 24 | $6,206 |
| Dexcom, Inc. | 29 | $799 |
| Medtronic(2 entities) | 21 | $603 |
| Corcept Therapeutics | 13 | $420 |
| Amgen(2 entities) | 20 | $336 |
| AbbVie | 16 | $260 |
| Lilly USA, LLC | 15 | $236 |
| Sanofi-aventis U.S. LLC | 11 | $208 |
| Xeris Pharmaceuticals, Inc. | 12 | $185 |
| Tolmar, Inc. | 24 | $181 |
| Pfizer | 12 | $180 |
| Amarin Pharma, Inc. | 10 | $172 |
| Mannkind Corporation | 7 | $141 |
| Sequel Med Tech, LLC | 1 | $139 |
| Boehringer Ingelheim | 7 | $113 |
| Bayer | 6 | $98 |
| Recordati_rare_diseases_inc. | 6 | $97 |
| Lifescan, Inc. | 5 | $82 |
| Regeneron Healthcare Solutions, Inc. | 3 | $61 |
| Shire North American Group Inc | 3 | $55 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $48 |
| BD | 2 | $45 |
| IBSA Pharma Inc. | 3 | $44 |
| Neurocrine Biosciences, Inc. | 2 | $43 |
| Insulet Corporation | 3 | $41 |
| Esperion Therapeutics, Inc. | 2 | $39 |
| Novartis | 2 | $35 |
| Nestle Healthcare Nutrition Inc. | 2 | $34 |
| EUSA Pharma (US) LLC | 2 | $27 |
| Clarus Therapeutics Inc. | 2 | $20 |
| Radius Health, Inc. | 1 | $20 |
| OPKO Pharmaceuticals, LLC | 1 | $20 |
| Vivus LLC | 1 | $18 |
| Verity Pharmaceuticals Inc. | 1 | $15 |
| Endo Pharmaceuticals Inc. | 1 | $12 |
How this compares
$148,198 in reported general payments places this provider in the 85th percentile of 90 endocrinology, diabetes & metabolism providers in Kentucky.
See all endocrinology, diabetes & metabolism providers in Kentucky →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in Covington
- Wael EidCovington$509K
- Linda HermillerCovington$12K
- Jaspreet ChahalCovington$11K
- Ailleen Heras HerzigCovington$5K
- Irina KorablevaCovington$4K
- Harold BaysLouisville$12.9M
- Bradley EilermanFlorence$1.9M
- Sergio Chang FigueroaMadisonville$1.2M
- Hisham AlrefaiLouisville$720K
- Lyle MyersLexington$434K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.